Gossamer Bio (GOSS) Financials: Revenue & Earnings
GOSS$10.19+0.42 +4.30%
$62.27M
Market Cap
—
P/E
—
Forward P/E
—
Score
Gossamer Bio (GOSS) Financials: Revenue & Earnings
GOSS price $10.19 +0.42 +4.30%
- Ticker
- GOSS
- Price
- $10.19
- Change
- +0.42 +4.30%
- Market cap ?
- $62.27M
- Beta ?
- 2.00
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
GOSS fair value $192.72. Price $10.19. Price is 95% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Model uncertainty high for this stock
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-04 | — | -3.93 | — | 12.16M |
| 2026-08-13 | -6.40 | -9.87 | 9.24M | 3.63M |
| 2026-05-18 | -0.20 | -13.60 | 16.95M | 4.67M |
| 2026-03-18 | -0.21 | -16.00 | 13.80M | 7.52M |
| 2025-11-06 | -16.80 | -15.20 | 13.29M | 6.38M |
| 2025-08-11 | -0.17 | -14.40 | 11.49M | 5.41M |
| 2025-05-15 | -12.80 | -15.20 | 9.89M | 4.07M |
| 2025-03-14 | -0.15 | -13.60 | 9.38M | 6.83M |
| 2024-11-07 | -11.20 | -12.00 | 9.48M | 8.53M |
| 2024-08-12 | 17.60 | 18.40 | 95.84M | 114.29M |
| 2024-05-07 | -15.20 | -15.20 | — | — |
| 2024-03-15 | -16.80 | -16.80 | — | — |
| 2023-11-09 | -16.80 | -20.80 | — | — |
| 2023-08-09 | -0.45 | -39.20 | — | — |
| 2023-05-08 | -0.52 | -42.40 | — | — |
| 2023-03-17 | -0.59 | -49.60 | — | — |
| 2022-11-03 | -0.65 | -0.66 | — | — |
| 2022-08-09 | -0.74 | -0.67 | — | — |
| 2022-05-10 | -60.80 | -0.77 | — | — |
| 2022-03-03 | -0.74 | -0.74 | — | — |
| 2021-11-08 | -0.80 | -0.78 | — | — |
| 2021-08-09 | -0.80 | -0.77 | — | — |
| 2021-05-06 | -0.78 | -0.80 | — | — |
| 2021-02-25 | -0.88 | -0.80 | — | — |
| 2020-11-10 | -0.80 | -0.86 | — | — |
| 2020-08-11 | -1.00 | -0.84 | — | — |
| 2020-05-12 | -0.87 | -0.80 | — | — |
| 2020-03-24 | -0.89 | -0.80 | — | — |
| 2019-11-12 | -0.80 | -0.71 | — | — |
| 2019-08-08 | -0.74 | -0.56 | — | — |
| 2019-05-14 | -0.90 | -0.63 | — | — |
| 2019-03-22 | -1,458.40 | -80.00 | — | — |
| 2019-02-12 | -1.99 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-23 | Milligan Sandra | Buy | 10.00K | $10.99 | 109.90K |
| 2026-09-23 | Daniel Thomas O | Buy | 10.00K | $10.99 | 109.90K |
| 2026-09-23 | Ciongoli Gregory Austin | Buy | 30.00K | $10.99 | 329.70K |
| 2026-09-23 | Drynan Skye | Buy | 10.00K | $10.99 | 109.90K |
| 2026-09-23 | Quisel John D | Buy | 10.00K | $10.99 | 109.90K |
| 2026-09-23 | Cox Russell J. | Buy | 10.00K | $10.99 | 109.90K |
| 2026-09-23 | Nathan Steven D | Buy | 10.00K | $10.99 | 109.90K |
| 2026-08-24 | Ciongoli Gregory Austin | Other | 250 | $0.00 | 0 |
| 2026-08-24 | Christian Waage | Buy | 2.90M | $0.17 | 507.50K |
| 2026-08-24 | Peterson Caryn | Buy | 5.80M | $0.17 | 1.02M |
| 2026-08-24 | Smith Robert Paul JR | Buy | 5.80M | $0.17 | 1.02M |
| 2026-08-24 | Giraudo Bryan | Buy | 5.80M | $0.17 | 1.02M |
| 2026-08-24 | Giraudo Bryan | Buy | 25 | $0.00 | 0 |
| 2026-08-24 | Hasnain Faheem | Buy | 5.80M | $0.17 | 1.02M |
| 2026-08-24 | Hasnain Faheem | Buy | 166 | $0.00 | 0 |
| 2026-06-04 | Quisel John D | Buy | 115.00K | $0.18 | 20.47K |
| 2026-06-04 | Drynan Skye | Buy | 115.00K | $0.18 | 20.47K |
| 2026-06-04 | Daniel Thomas O | Buy | 115.00K | $0.18 | 20.47K |
| 2026-06-04 | Cox Russell J. | Buy | 115.00K | $0.18 | 20.47K |
| 2026-06-04 | Milligan Sandra | Buy | 115.00K | $0.18 | 20.47K |
| 2026-06-04 | Nathan Steven D | Buy | 115.00K | $0.18 | 20.47K |
| 2026-03-19 | Aranda Richard | Buy | 572.00K | $0.45 | 257.40K |
| 2026-03-19 | Aranda Richard | Buy | 562.50K | $0.45 | 253.12K |
| 2026-03-19 | Aranda Richard | Buy | 487.50K | $0.45 | 219.38K |
| 2026-03-19 | Aranda Richard | Buy | 162.50K | $0.45 | 73.12K |
| 2026-03-19 | Aranda Richard | Buy | 157.50K | $0.45 | 70.88K |
| 2026-03-19 | Aranda Richard | Buy | 126.67K | $0.45 | 57.00K |
| 2026-03-19 | Aranda Richard | Buy | 40.00K | $0.45 | 18.00K |
| 2026-03-19 | Aranda Richard | Buy | 30.00K | $0.45 | 13.50K |
| 2026-03-19 | Aranda Richard | Buy | 22.78K | $0.45 | 10.25K |
| 2026-03-19 | Aranda Richard | Buy | 20.00K | $0.45 | 9.00K |
| 2026-03-19 | Aranda Richard | Buy | 9.17K | $0.45 | 4.13K |
| 2026-03-19 | Aranda Richard | Sell | 157.50K | $1.21 | 190.57K |
| 2026-03-19 | Aranda Richard | Sell | 162.50K | $0.84 | 136.18K |
| 2026-03-19 | Aranda Richard | Sell | 487.50K | $0.97 | 472.88K |
| 2026-03-19 | Aranda Richard | Sell | 562.50K | $2.88 | 1.62M |
| 2026-03-19 | Aranda Richard | Sell | 572.00K | $1.13 | 646.36K |
| 2026-03-19 | Aranda Richard | Sell | 30.00K | $1.36 | 40.80K |
| 2026-03-19 | Aranda Richard | Sell | 157.50K | $2.16 | 340.20K |
| 2026-03-19 | Peterson Caryn | Buy | 506.25K | $0.45 | 227.81K |
| 2026-03-19 | Peterson Caryn | Buy | 440.00K | $0.45 | 198.00K |
| 2026-03-19 | Peterson Caryn | Buy | 375.00K | $0.45 | 168.75K |
| 2026-03-19 | Peterson Caryn | Buy | 157.50K | $0.45 | 70.88K |
| 2026-03-19 | Peterson Caryn | Buy | 126.67K | $0.45 | 57.00K |
| 2026-03-19 | Peterson Caryn | Buy | 125.00K | $0.45 | 56.25K |
| 2026-03-19 | Peterson Caryn | Buy | 32.33K | $0.45 | 14.55K |
| 2026-03-19 | Peterson Caryn | Buy | 22.78K | $0.45 | 10.25K |
| 2026-03-19 | Peterson Caryn | Buy | 21.17K | $0.45 | 9.53K |
| 2026-03-19 | Peterson Caryn | Buy | 18.83K | $0.45 | 8.48K |
| 2026-03-19 | Peterson Caryn | Buy | 9.17K | $0.45 | 4.13K |
| 2026-03-19 | Peterson Caryn | Sell | 506.25K | $2.88 | 1.46M |
| 2026-03-19 | Peterson Caryn | Sell | 440.00K | $1.13 | 497.20K |
| 2026-03-19 | Peterson Caryn | Sell | 375.00K | $0.97 | 363.75K |
| 2026-03-19 | Peterson Caryn | Sell | 125.00K | $0.84 | 104.75K |
| 2026-03-19 | Peterson Caryn | Sell | 157.50K | $1.21 | 190.57K |
| 2026-03-19 | Peterson Caryn | Sell | 157.50K | $2.16 | 340.20K |
| 2026-03-19 | Peterson Caryn | Sell | 32.33K | $1.36 | 43.97K |
| 2026-03-19 | Smith Robert Paul JR | Buy | 572.00K | $0.45 | 257.40K |
| 2026-03-19 | Smith Robert Paul JR | Buy | 562.50K | $0.45 | 253.12K |
| 2026-03-19 | Smith Robert Paul JR | Sell | 562.50K | $2.88 | 1.62M |
| 2026-03-19 | Smith Robert Paul JR | Sell | 572.00K | $1.13 | 646.36K |
| 2026-03-19 | Hasnain Faheem | Buy | 1.68M | $0.45 | 756.00K |
| 2026-03-19 | Hasnain Faheem | Buy | 1.54M | $0.45 | 693.00K |
| 2026-03-19 | Hasnain Faheem | Buy | 1.31M | $0.45 | 590.62K |
| 2026-03-19 | Hasnain Faheem | Buy | 650.00K | $0.45 | 292.50K |
| 2026-03-19 | Hasnain Faheem | Buy | 544.50K | $0.45 | 245.03K |
| 2026-03-19 | Hasnain Faheem | Buy | 437.50K | $0.45 | 196.88K |
| 2026-03-19 | Hasnain Faheem | Buy | 325.00K | $0.45 | 146.25K |
| 2026-03-19 | Hasnain Faheem | Buy | 47.00K | $0.45 | 21.15K |
| 2026-03-19 | Hasnain Faheem | Buy | 43.50K | $0.45 | 19.57K |
| 2026-03-19 | Hasnain Faheem | Sell | 43.50K | $22.10 | 961.35K |
| 2026-03-19 | Hasnain Faheem | Sell | 47.00K | $12.10 | 568.70K |
| 2026-03-19 | Hasnain Faheem | Sell | 325.00K | $9.79 | 3.18M |
| 2026-03-19 | Hasnain Faheem | Sell | 650.00K | $11.94 | 7.76M |
| 2026-03-19 | Hasnain Faheem | Sell | 544.50K | $2.16 | 1.18M |
| 2026-03-19 | Hasnain Faheem | Sell | 544.50K | $1.21 | 658.85K |
| 2026-03-19 | Hasnain Faheem | Sell | 437.50K | $0.84 | 366.62K |
| 2026-03-19 | Hasnain Faheem | Sell | 1.31M | $0.97 | 1.27M |
| 2026-03-19 | Hasnain Faheem | Sell | 1.54M | $1.13 | 1.74M |
| 2026-03-19 | Hasnain Faheem | Sell | 1.68M | $2.88 | 4.84M |
| 2026-03-19 | Giraudo Bryan | Buy | 693.75K | $0.45 | 312.19K |
| 2026-03-19 | Giraudo Bryan | Buy | 638.00K | $0.45 | 287.10K |
| 2026-03-19 | Giraudo Bryan | Buy | 543.75K | $0.45 | 244.69K |
| 2026-03-19 | Giraudo Bryan | Buy | 211.50K | $0.45 | 95.17K |
| 2026-03-19 | Giraudo Bryan | Buy | 181.25K | $0.45 | 81.56K |
| 2026-03-19 | Giraudo Bryan | Buy | 176.67K | $0.45 | 79.50K |
| 2026-03-19 | Giraudo Bryan | Buy | 100.00K | $0.45 | 45.00K |
| 2026-03-19 | Giraudo Bryan | Buy | 96.67K | $0.45 | 43.50K |
| 2026-03-19 | Giraudo Bryan | Buy | 60.00K | $0.45 | 27.00K |
| 2026-03-19 | Giraudo Bryan | Buy | 47.67K | $0.45 | 21.45K |
| 2026-03-19 | Giraudo Bryan | Sell | 693.75K | $2.88 | 2.00M |
| 2026-03-19 | Giraudo Bryan | Sell | 638.00K | $1.13 | 720.94K |
| 2026-03-19 | Giraudo Bryan | Sell | 543.75K | $0.97 | 527.44K |
| 2026-03-19 | Giraudo Bryan | Sell | 181.25K | $0.84 | 151.89K |
| 2026-03-19 | Giraudo Bryan | Sell | 211.50K | $1.21 | 255.91K |
| 2026-03-19 | Giraudo Bryan | Sell | 211.50K | $2.16 | 456.84K |
| 2026-03-19 | Giraudo Bryan | Sell | 96.67K | $1.36 | 131.47K |
| 2026-03-19 | Christian Waage | Buy | 506.25K | $0.45 | 227.81K |
| 2026-03-19 | Christian Waage | Buy | 440.00K | $0.45 | 198.00K |
| 2026-03-19 | Christian Waage | Buy | 375.00K | $0.45 | 168.75K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 176, holders -23 vs prior quarter. Ownership 158.71%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| D. E. SHAW & CO., INC. | 40.96M | 40.57M | +10417.73% | 6.74M |
| 683 CAPITAL MANAGEMENT, LLC | 39.20M | 34.20M | +683.98% | 6.45M |
| DEEPCURRENTS INVESTMENT GROUP LLC | 37.67M | 37.67M | New | 6.03M |
| CONTEXT CAPITAL MANAGEMENT, LLC | 28.95M | 28.95M | New | 4.76M |
| WORTH VENTURE PARTNERS, LLC | 25.02M | 25.02M | New | 4.12M |
| AQR CAPITAL MANAGEMENT LLC | 15.63M | 5.50M | +54.34% | 2.57M |
| GSA CAPITAL PARTNERS LLP | 14.99M | 11.73M | +360.54% | 2.47M |
| WOLVERINE ASSET MANAGEMENT LLC | 12.89M | 12.89M | New | 2.12M |
| RENAISSANCE TECHNOLOGIES LLC | 11.63M | 10.41M | +854.94% | 1.91M |
| KALEHUA CAPITAL MANAGEMENT LLC | 11.15M | 913.07K | +8.92% | 1.84M |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.42M | 21.43K | +0.23% | 1.55M |
| ARCH VENTURE MANAGEMENT, LLC | 8.06M | 0 | 0.00% | 1.33M |
| BARCLAYS PLC | 7.83M | 4.77M | +155.48% | 1.29M |
| OCTAGON CAPITAL ADVISORS LP | 7.75M | 0 | 0.00% | 1.28M |
| BLACKROCK, INC. | 7.67M | -9.16M | -54.42% | 1.26M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 7.57M | 7.57M | New | 1.25M |
| TWO SIGMA INVESTMENTS, LP | 7.43M | 2.65M | +55.45% | 1.22M |
| SAMSARA BIOCAPITAL, LLC | 7.22M | 0 | 0.00% | 1.19M |
| QUBE RESEARCH & TECHNOLOGIES LTD | 7.07M | 2.15M | +43.68% | 1.16M |
| CORIENT PRIVATE WEALTH LP | 5.63M | 1.65M | +41.33% | 927.14K |
| SIREN, L.L.C. | 5.21M | 0 | 0.00% | 857.40K |
| HHLR ADVISORS, LTD. | 4.97M | 0 | 0.00% | 818.73K |
| UBS GROUP AG | 3.09M | 1.21M | +64.25% | 510.47K |
| SQUAREPOINT OPS LLC | 2.56M | -842.38K | -24.78% | 420.78K |
| GEODE CAPITAL MANAGEMENT, LLC | 2.48M | -2.46M | -49.76% | 408.71K |
Earnings and financials
Gossamer Bio, Inc. (GOSS) trades at $10.19, with a market cap of $62.27M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn